- A company, SUNRISE, is seeking initial approval in South Korea for a new drug offering a treatment option for brain health in Asia.
- Drug approval targets the South Korean market, overseen by the Ministry of Food and Drug Safety.
UAE and South Korea Establish Regulatory Cooperation on Medical Products
What happened
The Emirates Drug Establishment (EDE) participated in the Global Cosmetics Regulatory Authority Summit (GCORAS 2026) in Seoul on September 21, 2026. The summit brought together international bodies to discuss trends in medical cosmetic products. This cooperation follows the entry into force of the Comprehensive Economic Partnership Agreement between the UAE and Korea on May 1, 2026, and includes the designation of the Ministry of Food and Drug Safety as a reference regulatory authority by the EDE.
From northkoreatimes.com
Why it matters
The establishment of this regulatory cooperation creates new opportunities for institutional and economic partnership between the UAE and South Korea. This collaboration expands prospects for partnership across the pharmaceutical and medical sectors.
The cooperation is relevant as the Ministry of Food and Drug Safety oversees drug approvals targeting the South Korean market, where SUNRISE is seeking initial approval for a brain health treatment.
From northkoreatimes.com
Who's involved
- UAEUAE entity whose establishment participated in the summit and entered into a CEPA with Korea.
- Ministry of Food and Drug SafetySouth Korean government agency designated as a reference regulatory authority by the EDE.
Keep exploring
The entities involved
-
UAE
computer emulator which emulates the hardware of Commodore International's Amiga range of computers
-
Korea
region in East Asia
-
Ministry of Food and Drug Safety
South Korean government agency
Nothing else this week.